Browsing Tag
USA
3965 posts
Alphabet announces $19.7bn net income for Q3 2023, marking 41.5% yearly growth
Alphabet, the parent organization of Google, has shared its Q3 2023 financial performance, registering a significant net income…
October 25, 2023
Microsoft posts $56.5bn revenue for Q3 2023, up by 13% YoY
Microsoft Corp. has released its financial performance for the quarter ending September 30, 2023, showcasing a revenue of…
October 25, 2023
Ormat Technologies to acquire US renewable energy portfolio from Enel Green Power for $271m
Ormat Technologies, Inc. (NYSE: ORA), a key player in the renewable energy sector, is set to diversify its…
October 25, 2023
Aurobindo Pharma subsidiary earns FDA approval for Testosterone Cypionate Injection
In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited’s dedicated subsidiary, Eugia Pharma Specialities Limited, has…
October 25, 2023
Explosive news! US and allies under siege with 13 attacks in one week!
A staggering revelation by the Pentagon has shaken the global political scenario! American and its allied forces in…
October 25, 2023
Lilly’s Retevmo outperforms in trials for RET fusion-positive NSCLC and RET-mutant MTC
Eli Lilly (Lilly) has disclosed the results from two pivotal Phase 3 studies, LIBRETTO-431 and LIBRETTO-531, evaluating the…
October 24, 2023
Lupin gains FDA nod for generic Diflucan Tablets production
Lupin Limited, a recognized global pharmaceutical powerhouse, proudly announced its receipt of the much-anticipated approval from the US…
October 24, 2023
Ellington Financial, Great Ajax terminate merger agreement: Key details revealed
In a significant development from the real estate investment trust sector, Ellington Financial Inc. (NYSE: EFC), recognized for…
October 23, 2023
FDA expands VOXZOGO approval for all ages with open growth plates
BioMarin Pharmaceutical Inc., a leading global biotechnology entity, unveiled that its drug, VOXZOGO (vosoritide), has received the green…
October 23, 2023
Roche announces $7.1bn deal to acquire Telavant and RVT-3101 antibody
Switzerland-based Roche has officially declared its acquisition agreement for Telavant Holdings, Inc., a Roivant company collaboratively owned by…
October 23, 2023